Alpha 2.0
Login Register
» Articles » PMID: 14504378

Neuroprotection in PD--a Role for Dopamine Agonists?

Overview
Journal Neurology
Specialty Neurology
Date 2003 Sep 25
PMID 14504378
Citations 11
Authors
A H V Schapira
Affiliations
Soon will be listed here.
Citing Articles

A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity.

Muddapu V, Mandali A, Chakravarthy V, Ramaswamy S Front Neural Circuits. 2019; 13:11.

PMID: 30858799 PMC: 6397878. DOI: 10.3389/fncir.2019.00011.

Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist.

Zhang J, Tan L Curr Neuropharmacol. 2015; 14(4):356-63.

PMID: 26644151 PMC: 4876591. DOI: 10.2174/1570159x14666151208114634.

Dopamine receptors and Parkinson's disease.

Hisahara S, Shimohama S Int J Med Chem. 2015; 2011:403039.

PMID: 25954517 PMC: 4411877. DOI: 10.1155/2011/403039.

Studies on sensitivity of zebrafish as a model organism for Parkinson's disease: Comparison with rat model.

Makhija D, Jagtap A J Pharmacol Pharmacother. 2014; 5(1):39-46.

PMID: 24554909 PMC: 3917164. DOI: 10.4103/0976-500X.124422.

Role of pramipexole in the management of Parkinson's disease.

Antonini A, Barone P, Ceravolo R, Fabbrini G, Tinazzi M, Abbruzzese G CNS Drugs. 2010; 24(10):829-41.

PMID: 20839895 DOI: 10.2165/11585090-000000000-00000.